Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.03 USD -1.28% Market Closed
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascendis Pharma A/S
Revenue Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Revenue
€317.6m
CAGR 3-Years
297%
CAGR 5-Years
75%
CAGR 10-Years
32%
Genmab A/S
CSE:GMAB
Revenue
kr19B
CAGR 3-Years
37%
CAGR 5-Years
43%
CAGR 10-Years
39%
Zealand Pharma A/S
CSE:ZEAL
Revenue
kr76.9m
CAGR 3-Years
-22%
CAGR 5-Years
12%
CAGR 10-Years
-7%
B
Bavarian Nordic A/S
CSE:BAVA
Revenue
kr6.1B
CAGR 3-Years
53%
CAGR 5-Years
57%
CAGR 10-Years
19%
F
Fluoguide AS
STO:FLUO
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Revenue
kr33.8m
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
6%

See Also

What is Ascendis Pharma A/S's Revenue?
Revenue
317.6m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Revenue amounts to 317.6m EUR.

What is Ascendis Pharma A/S's Revenue growth rate?
Revenue CAGR 10Y
32%

Over the last year, the Revenue growth was 167%. The average annual Revenue growth rates for Ascendis Pharma A/S have been 297% over the past three years , 75% over the past five years , and 32% over the past ten years .

Back to Top